News
Game of Thrones actor Kristian Nairn admitted that taking part in Strictly Come Dancing would have been a "huge challenge physically" just days before he quit the hit BBC show ...
1h
Bangkok Post on MSN'Friends' star Matthew Perry's drug dealer to plead guilty in overdose death
A California woman known as the "ketamine queen" has agreed to plead guilty to charges that she supplied the dose of the prescription anesthetic that killed Friends star Matthew Perry, prosecutors ...
Jasveen Sangha, 42, who authorities said ran an illegal narcotics "stash house" in the North Hollywood district of Los Angeles will plead guilty to five charges under a deal with federal prosecutors.
2hon MSN
'I'm seeing young people in their 20s wearing nappies because of ketamine - I need to talk about it'
Young adults are wearing pads and nappies because of ketamine use, a business owner has said. Paige Loraine who runs The ...
The woman nicknamed the “Ketamine Queen” has pleaded guilty to charges linked to the death of ‘Friends’ star Matthew Perry. Jasveen Sangha pleaded guilty to five charges: one count of maintaining a ...
Psilocybin, LSD and ayahuasca are classic psychedelics, or serotonergic hallucinogens, because they act via serotonin receptors to produce vivid perceptual changes and mystical-type experiences.
The episode “Sickofancy” depicted the likes of Apple CEO Tim Cook and Meta CEO Mark Zuckerberg trying to flatter the president with lavish gifts in exchange for favors.
South Park Season 27 Episode 3, *“Sickofancy”*, dives into AI, ketamine culture, ICE crackdowns, and Trump, while delivering Towelie’s darkest storyline yet.
The episode also took a swipe at Mark Zuckerburg and Tim Cook, while hinting at a bigger role for Satan to come.
South Park” brought back Towelie for a traumatic trip to Trump’s militarized Washington, as Tim Cook and other oligarchs made cameos ...
Season 27's ratings record-busting run continued Wednesday, with the third episode taking its focus off MAGA and toward the ...
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 MIAMI, FL / ACCESS Newswire / August 19, 2025 / MIRA Pharmaceuticals, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results